A study to compare two different doses of vitamin D supplementation in children with nephrotic syndrome
Phase 4
Completed
- Conditions
- Health Condition 1: N049- Nephrotic syndrome with unspecified morphologic changes
- Registration Number
- CTRI/2017/08/009339
- Lead Sponsor
- Jawaharlal Nehru Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 32
Inclusion Criteria
All children in the age group of 1-14 years with nephrotic syndrome and having frequent relapses/steroid dependence
Exclusion Criteria
1.Steroid resistant nephrotic syndrome/secondary nephrotic syndrome
2.Patients with other co-existing ailments which affect vitamin D levels, e.g. chronic or persistent diarrhea, chronic liver disease, or chronic kidney disease.
3.Children on long-term medications that affect vitamin D metabolism (except corticosteroids) such as anticonvulsants (phenobarbitone, phenytoin, carbamazepine, valproic acid), antifungals, antiretrovirals (ritononavir, sequinavir)
4.Patients not likely to follow-up or residing more than 100 Km form this hospital
5.Refusal to give consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method